For Sale

Fresenius Medical Care  |  Austintown, OH

$2,924,000  |  7.50% Cap

139 Javit Court, Austintown, OH 44515

A white building with a blue awning and the word davita on it

New OM Download

New OM Download

Exclusively listed by:


Nathan Huffman


(972) 865-7991 | nathan@phnlg.com


Broker of Record: Brian BrockmanBang Realty, Inc. | OH License #: BRK.2009000214

Facility Type Building Area (SF) Years Remaining Net Operating Income
Single Tenant

10,505 Square Feet

3 Years $219,316


Investment Highlights

 

  • 21 Stations Operating 6 Days a Week
  • 2.00% Annual Escalations
  • 23-Year Tenant History

 

Facility Type Building Area (SF) Years Remaining Net Operating Income
Single Tenant

10,505 Square Feet

3 Years $219,316
A white building with a blue awning and the word davita on it

Overview

Peranich Huffman Net Lease Group is pleased to exclusively present Fresenius Medical Care, located at 139 Javit Court, Austintown, OH. This offering provides investors the opportunity to acquire a property that is home to a national medical tenant, in a well-established business district. The ±10,505 SF dialysis facility is situated directly west of the largest city in and county seat of Mahoning County and is the only dialysis center within a 3-mile radius, benefiting from a consistent patient base.


Lease

The property is leased to Fresenius Medical Care under a long-term agreement most recently extended through November 30, 2028. The lease features a modified gross structure with an annual base rent of $240,459 ($22.89/SF), which increases by 2% annually. Two (2) additional renewal options remain, each for 5 years at Fair Market Value. Fresenius is responsible for occupancy-related expenses, minimizing landlord obligations.


Tenant

Fresenius Medical Care Holdings, Inc. (S&P: “BB+”) is the largest provider of kidney dialysis services in the U.S., operating 2,500+ clinics nationwide and serving over 200,000 patients annually. The company reported FY 2024 revenue of $20B+ and employs more than 120,000 people worldwide. Fresenius’ scale, medical expertise, and entrenched patient demand provide durable credit strength and income stability for investors.